Waters Corporation
WAT Healthcare Diagnostics & Research
Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024. In the quarter to June 2026, revenue grew 113.4%, EPS fell 156.3%, free cash flow grew 750.0% and total debt rose 308.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
Follow WAT
Waters Corporation 10-K filed Feb 23, 2026
What changed
Item 1A, Risk Factors, against the 10-K filed Feb 25, 2025: 108 added · 11 removed · 59 modified; 1 with only figures updated; 15 moved without change
178 more changes in this Item, word by word, in Powerpack.
Powerpack